Peritoneal Carcinomatosis

Peritoneal carcinomatosis is a condition where cancer has spread to the peritoneum. The peritoneum is a thin membrane that lines your abdominal cavity and covers the organs inside, such as your stomach and intestines. This condition usually develops when cancer from another part of the body, most often the ovaries, colon, or stomach, spreads to this lining.

What is Peritoneal Carcinomatosis?

Peritoneal carcinomatosis occurs when cancer cells spread to the peritoneum, the thin membrane lining your abdomen and covering your internal organs. It is usually a secondary cancer, meaning it has spread from a primary cancer elsewhere in the body, most commonly from the ovaries, colon, or stomach.

The peritoneum acts like a protective sac for your abdominal organs. It has two layers: one that lines the abdominal wall (parietal peritoneum) and another that covers the organs (visceral peritoneum). Between these layers is a small amount of fluid that allows organs to move smoothly. When cancer cells spread to the peritoneum, they can form tumors on its surface. This spread often happens when cancer cells break away from a primary tumor and travel through the abdominal fluid. These new tumors can grow and cause various problems within the abdomen. While most cases are secondary, a rare type of cancer called primary peritoneal cancer can start directly in the peritoneum. However, this is much less common than cancer spreading from other organs. Understanding the primary source of the cancer is crucial for diagnosis and treatment planning.

Symptoms

Symptoms of peritoneal carcinomatosis often include abdominal pain, bloating, and a feeling of fullness, usually due to fluid buildup (ascites). You might also experience nausea, vomiting, changes in bowel habits, and unexplained weight loss. These symptoms tend to worsen as the condition progresses.

One of the most common symptoms is abdominal swelling or bloating. This often happens because cancer cells irritate the peritoneum, causing it to produce too much fluid. This fluid buildup, called ascites, can make your abdomen feel tight and uncomfortable. As the tumors grow and fluid accumulates, you may also experience abdominal pain or discomfort. The pressure from the fluid and tumors can press on your stomach and intestines, leading to nausea, vomiting, and a feeling of being full very quickly, even after eating small amounts. Changes in your bowel habits, such as constipation or diarrhea, can also occur if the cancer affects the intestines. Unexplained weight loss and fatigue are common general symptoms of advanced cancer, including peritoneal carcinomatosis, as the body uses more energy to fight the disease.

Causes & risk factors

Peritoneal carcinomatosis is usually caused by the spread of cancer from another organ, most often the ovaries, colon, stomach, appendix, or pancreas. Risk factors are primarily those associated with the original cancer, as the condition itself is a complication of advanced disease rather than a standalone primary illness.

The most common cause is the spread (metastasis) of cancer from organs within the abdomen or pelvis. For example, ovarian cancer, colorectal cancer (colon or rectum), stomach cancer, and pancreatic cancer are frequent primary sources. Cancer of the appendix can also lead to peritoneal carcinomatosis. Cancer cells can spread to the peritoneum in several ways. They might break off from the original tumor and directly implant on the peritoneal surface. They can also travel through the lymphatic system or bloodstream, although direct spread within the abdominal cavity is more typical for peritoneal carcinomatosis. Since peritoneal carcinomatosis is generally a secondary condition, the risk factors are largely tied to the risk factors for the primary cancer. For instance, a history of certain cancers significantly increases the likelihood of developing this spread. Rarely, cancer can originate directly in the peritoneum, known as primary peritoneal cancer, which is distinct but presents similarly.

How it's diagnosed

Diagnosing peritoneal carcinomatosis typically involves a physical exam, imaging tests like CT, MRI, or PET scans, and often a procedure to obtain tissue or fluid samples. These samples are then examined under a microscope to confirm the presence of cancer cells and identify their origin.

Your doctor will start with a physical exam, checking for abdominal swelling or tenderness. They will also ask about your symptoms and medical history. Imaging tests are crucial for visualizing the abdomen and identifying tumors or fluid buildup. Common imaging tests include computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. These scans can show the extent of cancer spread and help determine if surgery is possible. To confirm the diagnosis, a biopsy is usually needed. This might involve a diagnostic laparoscopy, where a small incision is made to insert a camera and take tissue samples directly from the peritoneum. Alternatively, if there is significant fluid buildup (ascites), a procedure called paracentesis can be performed to remove fluid, which is then analyzed for cancer cells.

Treatment options

Treatment for peritoneal carcinomatosis often involves a combination of surgery and chemotherapy, tailored to the individual and the primary cancer type. Options can include extensive surgery to remove visible tumors (cytoreductive surgery), sometimes combined with heated chemotherapy directly in the abdomen (HIPEC), or systemic chemotherapy.

One common and often effective approach for selected patients is cytoreductive surgery (CRS). This extensive surgery aims to remove all visible tumors from the peritoneum and affected organs. It is a complex procedure performed by specialized surgical oncologists. CRS is frequently combined with hyperthermic intraperitoneal chemotherapy (HIPEC). After the tumors are surgically removed, a heated chemotherapy solution is circulated directly within the abdominal cavity for a short period. The heat helps the chemotherapy penetrate tissues and kill remaining microscopic cancer cells. Not all patients are candidates for CRS and HIPEC. Factors like the type of primary cancer, the extent of spread, and overall health determine eligibility. For those not suitable for surgery, or in addition to it, systemic chemotherapy (given intravenously) may be used to target cancer cells throughout the body. Targeted therapies and immunotherapies are also emerging options for some types of cancer. Palliative care is an important part of treatment, focusing on managing symptoms, improving quality of life, and providing support for patients and their families, regardless of the stage of the disease.

Recovery & outlook

The recovery and outlook for peritoneal carcinomatosis vary significantly, depending on the primary cancer, the extent of spread, and how well the treatment works. It is often a serious condition, but treatments like cytoreductive surgery with HIPEC can improve survival and quality of life for carefully selected patients.

Peritoneal carcinomatosis is generally considered an advanced stage of cancer, and the prognosis can be challenging. However, advances in treatment, particularly the combination of cytoreductive surgery and HIPEC, have improved outcomes for some individuals. Recovery from extensive treatments like CRS and HIPEC can be long and challenging, often requiring a hospital stay and a period of rehabilitation. Patients may experience fatigue, pain, and digestive issues during this time. The long-term outlook is highly individualized. Factors such as the type of original cancer (e.g., ovarian or colorectal cancer often have better outcomes with CRS/HIPEC than pancreatic cancer), the completeness of tumor removal, and the patient's overall health play a significant role. While a cure is not always possible, treatment aims to control the disease, extend life, and maintain the best possible quality of life.

When to see a doctor

You should see a doctor if you experience persistent or worsening abdominal pain, bloating, unexplained weight loss, or changes in your bowel habits. These symptoms, especially if new or severe, could indicate peritoneal carcinomatosis or another serious condition requiring prompt medical evaluation.

It is important to pay attention to your body and report any concerning symptoms to your healthcare provider. While many conditions can cause abdominal discomfort, persistent or worsening symptoms should always be investigated. Specifically, if you have a history of cancer, particularly ovarian, colorectal, stomach, or pancreatic cancer, and you develop new or worsening abdominal symptoms, it is crucial to seek medical advice promptly. Early detection, even of recurrent or metastatic disease, can sometimes open up more treatment options. Do not delay seeking medical attention for severe symptoms like sudden, intense abdominal pain, inability to pass gas or stool, or persistent vomiting, as these could indicate a bowel obstruction or other emergency. Your doctor can perform tests to determine the cause of your symptoms and recommend appropriate care.

Frequently asked questions

What is the peritoneum and why is it important?

The peritoneum is a thin, two-layered membrane that lines your entire abdominal cavity and covers most of the organs within it, such as your stomach, intestines, and liver. It helps protect these organs and allows them to move smoothly against each other, thanks to a small amount of lubricating fluid it produces.

Is peritoneal carcinomatosis always a sign of advanced cancer?

Yes, peritoneal carcinomatosis generally indicates that cancer has spread from its original site, meaning it is typically an advanced stage of cancer. It signifies that the disease is no longer localized to one organ but has spread to the lining of the abdomen.

What is HIPEC and how does it work?

HIPEC stands for hyperthermic intraperitoneal chemotherapy. It's a treatment where, after visible tumors are surgically removed, a heated chemotherapy solution is circulated directly inside your abdominal cavity for about 90 minutes. The heat helps the chemotherapy drugs better penetrate tissues and kill any remaining microscopic cancer cells.

Can peritoneal carcinomatosis be cured?

While a complete cure is challenging, especially for widespread disease, treatments like cytoreductive surgery combined with HIPEC can significantly improve outcomes and sometimes achieve long-term remission for carefully selected patients. For many, the goal is to control the disease, extend life, and improve quality of life.

What kind of doctor treats peritoneal carcinomatosis?

Peritoneal carcinomatosis is typically treated by a multidisciplinary team of specialists. This often includes surgical oncologists (especially those specializing in complex abdominal surgeries like CRS/HIPEC), medical oncologists who manage chemotherapy, and sometimes radiation oncologists or palliative care specialists.

How does peritoneal carcinomatosis affect daily life?

Peritoneal carcinomatosis can significantly impact daily life due to symptoms like pain, bloating, nausea, and fatigue. These symptoms can affect eating, mobility, and overall energy levels. Treatment side effects can also be challenging. Palliative care and supportive therapies are crucial for managing these impacts and improving quality of life.

Sources

• MedlinePlus — Peritoneal Carcinomatosis
• Mayo Clinic — Peritoneal Carcinomatosis
• Cochrane Library — Peritoneal Carcinomatosis